ED vs IRD · P/E 18, rev $15.26B vs rev $11.0M
Consolidated Edison Inc (ED) versus Opus Genetics, Inc. (IRD) — a side-by-side from cached financials, not a winner call.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Latest reported ED revenue for 2024-12-31 was $15.26B. Net income was $1.82B. Revenue was up 4.0% from 2023-12-31 to 2024-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
ED currently screens at market cap $36.02B and trailing P/E 18.3. IRD currently screens at market cap $35.7M.
Not investment advice. Open the ED and IRD stock pages for the full models.
Not investment advice.